Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2023 08:00 ET | Source: ReWalk Robotics Ltd.

Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd., (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative...
March 07, 2023 07:15 ET | Source: Lleida.net

Lleida.net erhält drei neue Patente in Europa und erreicht insgesamt 224 internationale Anerkennungen.

FRANKFURT AM MAIN, Deutschland, March 07, 2023 (GLOBE NEWSWIRE) -- Das Technologiedienstleistungsunternehmen Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) (9TV:FRA) hat drei Patente in drei der...
March 07, 2023 05:00 ET | Source: Epazz, Inc.

Epazz Receives Official Issuance of Utility Patent From the US Patent Office for Its AI-Predictive Smart Charging Pad for ZenaDrone 1000

CHICAGO, IL, March 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Epazz Inc. (OTC: EPAZ), a mission-critical provider of drone technology, blockchain mobile apps and cloud-based business software...
March 06, 2023 07:46 ET | Source: Lleida.net

Lleida.net receives three new patents in Europe and reaches a total of 224 international recognitions

MADRID, Spain, March 06, 2023 (GLOBE NEWSWIRE) -- The technology services company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) has received three patents in three of Europe's leading economies:...
March 02, 2023 09:15 ET | Source: Hepion Pharmaceuticals, Inc.

EPO Decision to Grant European Patent for Rencofilstat Further Strengthens Hepion’s Patent Portfolio

– Patent Covers 38 European Countries – – Rencofilstat’s Exclusivity May Extend into 2048 – EDISON, N.J., March 02, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a...
February 28, 2023 02:00 ET | Source: Cancer Advances Inc

Cancer Advances, Inc. Announces Issuance of New U.S. Patent

DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal (GI) cancers, announced that the U.S....
February 27, 2023 13:23 ET | Source: The Blinc Group

The Blinc Group Emerges Triumphant in ITC Investigation Brought by Chinese Ccell® Manufacturer

New York, NY, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Blinc Group, Inc. (Blinc), a leading innovator in the cannabis vaporizer industry, is pleased to announce that Judge Cheney, Chief Administrative...
February 27, 2023 12:00 ET | Source: Bubblr Inc.

Bubblr Inc. Announces Strategic New Patent Filed With the U.S. Patent and Trademark Office

New York, NY, Feb. 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Bubblr Inc. (OTC PINK: BBLR), an ethical technology company focused on the development of an Ethical Web Open-Source platform for...
February 27, 2023 08:00 ET | Source: PDS Biotechnology Corporation

PDS Biotech Completes Successful Meeting with FDA for Triple Combination of PDS0101, PDS0301 and a Commercial Immune Checkpoint Inhibitor

FLORHAM PARK, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
February 24, 2023 08:00 ET | Source: Windtree Therapeutics

Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office

WARRINGTON, Pa., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage...